<p><strong>Treatment of deep vein thrombosis, with or without pulmonary embolism</strong>: Subcutaneously 100 anti-Xa lU/kg twice daily for 10 days or Subcutaneously 150 anti-Xa lU/kq once daily for 10 days. Oral anticoagulant therapy should be initiated when appropriate and Enoxaparin Sodium treatment should be continued until a therapeutic anticoaqulant effect has been achieved.<br />
<br />
<strong>Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin</strong>: Subcutaneously 100 anti-Xa lU/kg twice daily for 2- 8 days. Should be administered concurrently with oral aspirin (100 to 325 mg once daily). Treatment with Enoxaparin Sodium in these patients should be prescribed fora minimum of 2 days and continued until clinical stabilization.<br />
<br />
<strong>Prevention of thrombus formation in extra corporeal circulation during hemodialysis</strong>: Recommended dose is 100 anti-Xa lU/kg. For patients with a high risk of hemorrhage, the dose should be reduced to 50 anti-Xa lU/kg for double vascular access or 75 anti-Xa lU/kg for single vascular access. During hemodialysis, Enoxaparin Sodium should be introduced into the arterial line of the circuit at the beqinninq of the dialysis session.<br />
<br />
Prophylaxis of venous thromboembolic disease in surgical patients:</p>

<ul>
	<li><strong>Patients undergoing general surgery with a moderate risk of thromboembolism (e.g. abdominal surgery)</strong>: Subcutaneously 2000 anti-Xa IU (0.2 ml) or 4000 anti-Xa IU (0.4 ml) once daily for 7 to 10 days. The first injection should be given 2 hours before the surgical procedure.</li>
	<li><strong>Patients undergoing orthopedic surgery with a high risk of thromboembolism</strong>: Subcutaneously 4000 anti-Xa IU (0.4 ml) once daily for 7 to 10 days. The first injection should be given 12 hours before the surgical procedure. Longer treatment duration may be appropriate in some patients like continued therapy with 4000 anti-Xa IU once daily for 3 weeks following the initial therapy has been proven to be beneficial in orthopaedic surqery.</li>
</ul>

<p><strong>Prophylaxis of venous thromboembolic disease in medical patients</strong>: Subcutaneously 4000 anti-Xa IU (0.4 ml) once daily for 6- 14 days.</p>

<p><a href="https://medex.com.bd/news/104/danger-of-taking-medication-without-doctors-advice" target="_blank"><em>* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন</em></a>&#39;</p>